The current valuation score of Genmab A/S is 9.28, ranking 44 out of 388 in the Biotechnology & Medical Research industry. Its current P/E ratio is 19.48, which is 5.20% below the recent high of 20.50 and 94.82% above the recent low of 1.01.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.